罕见功能丧失遗传变异调控体脂分布的鉴定
研究结合英国生物银行450 562人的阵列罕见非同义变异全基因组分析与184 246人的外显子测序罕见功能丧失(LoF)基因负荷检验,发现PLIN1、INSR、ACVR1C和PDE3B的LoF与体重指数校正后腰臀比改善及臀股脂肪量增加相关,而PLIN4的LoF则产生不利影响。表型随访提示PLIN1、PDE3B和ACVR1C的LoF对代谢表型有益并降低心血管疾病风险,INSR的LoF与较低甘油三酯和高密度脂蛋白水平相关但可能增加2型糖尿病风险。
要点
- PLIN1、INSR、ACVR1C和PDE3B的LoF变异与体重指数校正后腰臀比改善及臀股脂肪量增加相关。
- PLIN4的LoF变异对体重指数校正后腰臀比和臀股脂肪量产生不利影响。
- PLIN1、PDE3B和ACVR1C的LoF对代谢表型有益并降低心血管疾病风险,INSR的LoF可能增加2型糖尿病风险。
核心结论
- 本研究稳健地表明这些基因参与体脂分布的调控,为靶向这些分子的治疗潜力提供了新且部分反直觉的见解。
研究设计与样本
- 研究结合英国生物银行450 562人的阵列罕见非同义变异全基因组分析与184 246人的外显子测序罕见LoF基因负荷检验。
主要发现
- PLIN1 LoF变异P=5.86×10-7、INSR LoF变异P=6.21×10-7、ACVR1C LoF+中等影响变异P=1.68×10-7(中等影响变异P=4.57×10-7)、PDE3B LoF变异P=1.41×10-6,均与体重指数校正后腰臀比改善及臀股脂肪量增加相关。
- PLIN4 LoF变异P=5.86×10-7,对体重指数校正后腰臀比和臀股脂肪量产生不利影响。
- 表型随访提示PLIN1、PDE3B和ACVR1C的LoF对代谢表型(如甘油三酯和高密度脂蛋白胆固醇浓度)有益并降低心血管疾病风险,而PLIN4 LoF对健康有不良后果。
- INSR LoF与较低甘油三酯和高密度脂蛋白水平相关,但可能增加2型糖尿病风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Biological and translational insights from large-scale, array-based genetic studies of fat distribution, a key determinant of metabolic health, have been limited by the difficulty in linking predominantly noncoding variants to specific gene targets. Rare coding variant analyses provide greater confidence that a specific gene is involved, but do not necessarily indicate whether gain or loss of function (LoF) would be of most therapeutic benefit. OBJECTIVE: This work aimed to identify genes/proteins involved in determining fat distribution. METHODS: We combined the power of genome-wide analysis of array-based rare, nonsynonymous variants in 450 562 individuals in the UK Biobank with exome-sequence-based rare LoF gene burden testing in 184 246 individuals. RESULTS: The data indicate that the LoF of 4 genes (PLIN1 [LoF variants, P = 5.86 × 10-7], INSR [LoF variants, P = 6.21 × 10-7], ACVR1C [LoF + moderate impact variants, P = 1.68 × 10-7; moderate impact variants, P = 4.57 × 10-7], and PDE3B [LoF variants, P = 1.41 × 10-6]) is associated with a beneficial effect on body mass index-adjusted waist-to-hip ratio and increased gluteofemoral fat mass, whereas LoF of PLIN4 (LoF variants, P = 5.86 × 10-7 adversely affects these parameters. Phenotypic follow-up suggests that LoF of PLIN1, PDE3B, and ACVR1C favorably affects metabolic phenotypes (eg, triglycerides [TGs] and high-density lipoprotein [HDL] cholesterol concentrations) and reduces the risk of cardiovascular disease, whereas PLIN4 LoF has adverse health consequences. INSR LoF is associated with lower TG and HDL levels but may increase the risk of type 2 diabetes. CONCLUSION: This study robustly implicates these genes in the regulation of fat distribution, providing new and in some cases somewhat counterintuitive insight into the potential consequences of targeting these molecules therapeutically.
引用
- Koprulu M, Zhao Y, Wheeler E, et al. Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution. J Clin Endocrinol Metab. 2022. PMID: 34875679. doi:10.1210/clinem/dgab877
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。